Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Synagis Prescribers (US)

Articles with lock require a subscription to GLG News | Request a free trial
April 1, 2008
First OTC Diagnostic Testing, then Home-based Auto-surgery?
Analysis of: The Outlook on Home, Direct Access Testing | www.aacc.org
Author: GLG Expert Contributor
Sometimes I wonder what I got out of all the years I spent in training?
March 31, 2008
So it begins...
Analysis of: FDA Investigating Possible Link Between Singulair and Suicide | www.foxnews.com
Author: GLG Expert Contributor
-Reports of suicidality have been added to Mercks' PI for Singulair -The media have begun to report on this in the past few days and patients are already making calls to their docs -A la Vioxx, Singulair is poised to become the next whipping boy for every depressed asthmatic...
March 24, 2008
Sure, and let's buy them all a pony, too!
Analysis of: Vaccinating Boys for Girls’ Sake? | www.nytimes.com
Author: GLG Expert Contributor
Everyone who thinks that the FDA is going to license a vaccine as costly as Gardasil for boys is insane (sorry if I'm being too subtle). Girls get cervical cancer; the rates of penile and anal cancers from HPV is minuscule in comparison. The cost of Gardasil for girls alone is going to strain a...
March 19, 2008
Health Plans Cannot Control Costs Any More Than Physicians Can
Analysis of: Health insurers take a dive on WellPoint's warning | www.marketwatch.com
Author: GLG Expert Contributor
Face the facts: In the US, health care costs are, in large part, demand driven. Sure, there is the supply push issue, but very few physicians actually would subject their patients to unnecessary services or procedures--and those who do continue to face censure and exclusion from insurance plans and...
March 7, 2008
Not Close to In Vivo Use yet
Analysis of: Phase II Clinical Trial of ALN-RSV01 Demonstrates Statistically Significant Anti-Viral Efficacy with an Approximately 40% Reduction in RSV Infection Rate and 95% Increase in Infection-Free Subjects | www.pipelinereview.com
Author: GLG Expert Contributor
This is a very interesting concept, especially since RSV, a major cause of illness in very young children, has been difficult to both prevent and treat. Should the process described here pan out, it opens the door to the development of clinical applications.
March 6, 2008
Is This a Meaningful Change?
Analysis of: FDA Approves Nexium for Use in Children Ages 1-11 Years | pharmalive.com
Author: GLG Expert Contributor
As is the case with choice of PPI's in adult patients, in pediatrics we now have a large number of effective drugs from which to choose. However, "managed care" policies limit the choices and make the prescribing of newer products problematic.
March 6, 2008
"I am Not a Doctor but I Play One on TV...."
Analysis of: Drug Pitchmen: Actor, Doctor or Pfizer’s Option | www.nytimes.com
Author: GLG Expert Contributor
Why is the Jarvik ad campaign any more offensive than the famous line quoted above? If any direct-to-consumer (DTC) advertising is acceptable, then why is there any furor over the use of actors who are not technically qualified as pitchmen?
March 6, 2008
An Unhappy Trend
Analysis of: Your Hospital's Deadly Secret | www.portfolio.com
Author: GLG Expert Contributor
As hospitals outsource everything, from laboratory management to emergency rooms to pharmacies, control of these areas is being lost, often to the detriment of patients.
March 6, 2008
Newer and More Effective Adjuvants are a Start
Analysis of: Intercell completes Phase I clinical trial for improved seasonal Flu vaccine formulated with IC31(R) | www.pipelinereview.com
Author: GLG Expert Contributor
While new adjuvants always hold promise, and Intercell's product seems to be efficacious without undue reactogenicity, any vaccine is only as good as its raw materials. This year's flu vaccine's lack of efficacy is a case in point.
March 3, 2008
Technology is all too often the CAUSE of increased health care spending
Analysis of: As Healthcare Spending is Predicted to Exceed 4 Trillion in Less Than 10 Years, Technology will be Called upon to Stem the Tide | biz.yahoo.com
Author: GLG Expert Contributor
New technology is one factor in the ever-increasing cost of healthcare.  New medical technologies  are seldom cost-saving.

Previous Page : 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Next61 to 70 of 156

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-01T09:45:16.773